Cited by 42Medicinal Plants and NeuroprotectionNeurological Disorders and TreatmentsNeurological Disease Mechanisms and Treatments

Nerve Protective Effect of Asiaticoside against Ischemia-Hypoxia in Cultured Rat Cortex Neurons

Open access
Sun, Tao, Liu, Bin, Li, Peng·2015·Medical Science Monitor

Abstract

BACKGROUND: Asiaticoside is one of the main functional components of the natural plant Centella asiatica urban. Studies have reported it has several functions such as anti-depression and nerve cell protection. Asiaticoside can reduce the cerebral infarct size in acute focal cerebral ischemia in a mouse model and asiatic acid glycosides can significantly improve neurobehavioral scores. Currently, there is a lack of understanding of asiaticoside in regard to its neural protective mechanism in cerebral ischemia. This study aimed to solve this problem by using an ischemia-hypoxia cell model in vitro. MATERIAL AND METHODS: An in vitro ischemia hypoxia cell model was successfully established by primary cultured newborn rat cortical neurons. After being treated by asiaticoside for 24 h, cell survival rate, lactate dehydrogenase release quantity, and B-cell lymphoma gene-2 (BCL-2), Bax, and caspase-3 protein expressions was detected. RESULTS: After 10 nmol/L or 100 nmol/L of asiaticoside were given to the cells, cell survival rate increased significantly and presented concentration dependence. Asiaticoside can reduce lactate dehydrogenase release. Lactate dehydrogenase release in model cells is gradually reduced with the increase of asiaticoside concentration. The lactate dehydrogenase release in asiaticoside 10 nmol/L group, asiaticoside 100 nmol/L group and ischemia hypoxia group were 26.75±1.05, 22.36±2.87 and 52.35±5.46%, respectively (p<0.05). It was also found that asiaticoside could modulate the expression of apoptotic factors, including bcl-2, Bax, and caspase-3. CONCLUSIONS: Asiaticoside helps to protect in vitro ischemia hypoxia neurons. This nerve cell protection may be mediated by the BCL-2 protein.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.12659/msm.894024

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Madecassoside and asiaticoside are implicated in the treatment of hypoxic-ischaemic injuries in the brain.

    “Madecassoside and asiaticoside are implicated in the treatment of hypoxic–ischaemic injuries in the brain 31 , 32”

    From Therapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review (2023) · cites this paper as [32]

    The Results and Discussion report that asiaticoside protected cultured rat cortical neurons under ischemia-hypoxia conditions, supporting its potential relevance to brain injury. The paper does not address madecassoside, and its Discussion says the findings are limited to cells studied in vitro rather than established treatment in animals or people. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Asiaticoside promotes ischaemia-hypoxia nerve cell survival by upregulating anti-apoptotic Bcl-2 and reducing apoptosis by suppressing pro-apoptotic Bax and caspase-3.

    “Asiaticoside has previously shown a protective effect on ischaemia‐hypoxia neural cells in‐vitro and promotes ischaemia‐hypoxia nerve cell survival rate by upregulating anti‐apoptotic protein Bcl‐2, reducing cell apoptosis by suppressing pro‐apoptotic factors Bax and caspase‐3.”

    From Therapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review (2023) · cites this paper as [32]

    The Results report increased Bcl-2, suppressed Bax and caspase-3, and reduced apoptosis after asiaticoside treatment of ischemia-hypoxia neurons. The Discussion links Bcl-2 upregulation to increased survival, but the Conclusions say the protective effect *may* be mediated by these proteins. The claim presents suppression of Bax and caspase-3 as an established cause of reduced apoptosis, which is stronger than the paper establishes. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Asiaticoside inhibits lactate dehydrogenase release by ischaemia-hypoxic cells and inhibits membrane lipid peroxidation, preventing damage to neuronal membranes and blocking ischaemia-associated neuron necrosis.

    “Asiaticoside can further inhibit lactate dehydrogenase release by ischaemia‐hypoxic cells and inhibit membrane lipid peroxidation, thereby preventing damage to neuronal membranes and blocking ischaemia‐associated neuron necrosis. 32”

    From Therapeutic Properties and Pharmacological Activities of Asiaticoside and Madecassoside: A Review (2023) · cites this paper as [32]

    The Discussion reports that asiaticoside inhibited lactate dehydrogenase release from ischemia-hypoxic cells. It says asiaticoside *may* inhibit membrane lipid peroxidation, thereby reducing neuron necrosis; the citing sentence presents that mechanism as established and describes necrosis as blocked rather than reduced. The study was limited to cultured rat neurons in vitro. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • In vitro studies show CAW whole extract and isolated compounds facilitate neurite outgrowth and elicit neuroprotection.

    “Previously, in vitro studies have shown that both CAW whole extract and isolated compounds (detailed in a review [32]) facilitate neurite outgrowth [6,28,106], and elicit neuroprotection [107,108,109,110,111].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Sun, T., Liu, B., & Li, P.
Affiliations
Zaozhuang Municipal Hospital (CN)
Corresponding author
Li, Peng
Venue
Medical Science Monitor
Published
2015
Volume
21
Pages
3036-3041
ISSN
  • 1234-1010 (ISSN-L)
  • 1643-3750
OpenAlex
W2216140872
Cited by
42
References
22
Citations by year
2026: 2 · 2025: 3 · 2024: 5 · 2023: 5 · 2022: 1 · 2021: 6 · 2020: 10 · 2019: 3 · 2018: 3 · 2017: 2 · 2016: 1 · 2015: 1
FWCI
4.58
Type
journal article
Language
en
Open access
Licence
cc-by-nc-nd
Locations
  • Medical Science Monitor (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
  • Life Sciences › Neuroscience › Neurology › Neurological Disorders and Treatments
  • Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
Keywords
asiaticoside, Centella asiatica, neuroprotection, cerebral ischemia, hypoxia-ischemia, cortical neurons, apoptosis, Bcl-2, Bax, caspase-3, lactate dehydrogenase release, neuroprotection mechanism
MeSH terms
Animals, Animals, Newborn, Cell Survival, Cells, Cultured, Cerebral Cortex, Brain Ischemia, Dilazep, Frontal Lobe, Gene Expression Regulation, L-Lactate Dehydrogenase, Memory, Neurons, Triterpenes, Rats, Sprague-Dawley, Apoptosis, Neuroprotective Agents, Proto-Oncogene Proteins c-bcl-2, Hypoxia-Ischemia, Brain, Centella, bcl-2-Associated X Protein, Rats, Caspase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review